应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GRFS 基立福
盘后交易 06-17 17:06:14 EDT
8.87
-0.22
-2.42%
盘后
8.87
+0.00
0.00%
16:04 EDT
最高
9.07
最低
8.86
成交量
45.31万
今开
9.07
昨收
9.09
日振幅
2.31%
总市值
60.35亿
流通市值
49.76亿
总股本
6.80亿
成交额
405.85万
换手率
0.08%
流通股本
5.61亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
小摩:维持Grifols(GRFS.US)评级,由中性调整至中性评级, 目标价由7.60美元调整至10.30美元。
金融界 · 06-17 21:09
小摩:维持Grifols(GRFS.US)评级,由中性调整至中性评级, 目标价由7.60美元调整至10.30美元。
美国法院认定有足够证据推进基立福对卖空机构的诉讼
环球市场播报 · 05-30
美国法院认定有足够证据推进基立福对卖空机构的诉讼
基立福盘中异动 下午盘快速拉升5.15%
市场透视 · 05-16
基立福盘中异动 下午盘快速拉升5.15%
基立福盘中异动 股价大跌5.09%
市场透视 · 05-14
基立福盘中异动 股价大跌5.09%
基立福盘中异动 大幅上涨5.05%
市场透视 · 05-13
基立福盘中异动 大幅上涨5.05%
基立福盘中异动 股价大跌5.16%
市场透视 · 03-11
基立福盘中异动 股价大跌5.16%
基立福盘中异动 早盘急速拉升5.02%报8.69美元
市场透视 · 03-05
基立福盘中异动 早盘急速拉升5.02%报8.69美元
基立福在西班牙马德里交易所涨幅扩大至12%。
金融界 · 02-27
基立福在西班牙马德里交易所涨幅扩大至12%。
基立福盘中异动 股价大涨5.16%
市场透视 · 02-27
基立福盘中异动 股价大涨5.16%
基立福盘中异动 临近午盘股价大涨5.42%
市场透视 · 02-27
基立福盘中异动 临近午盘股价大涨5.42%
基立福盘中异动 下午盘股价大跌5.11%
市场透视 · 02-26
基立福盘中异动 下午盘股价大跌5.11%
基立福盘中异动 早盘股价大涨5.06%
市场透视 · 02-13
基立福盘中异动 早盘股价大涨5.06%
基立福盘中异动 早盘大幅下跌5.27%报7.01美元
市场透视 · 01-23
基立福盘中异动 早盘大幅下跌5.27%报7.01美元
上海莱士预计2025年度与基立福下属公司的交易额为5.2亿美元
财中社 · 01-22
上海莱士预计2025年度与基立福下属公司的交易额为5.2亿美元
基立福盘中异动 大幅上涨5.10%报7.42美元
市场透视 · 01-16
基立福盘中异动 大幅上涨5.10%报7.42美元
基立福盘中异动 股价大跌5.00%报7.22美元
市场透视 · 01-10
基立福盘中异动 股价大跌5.00%报7.22美元
基立福盘中异动 早盘股价大跌5.10%报7.45美元
市场透视 · 2024-12-27
基立福盘中异动 早盘股价大跌5.10%报7.45美元
基立福盘中异动 下午盘股价大涨5.05%报7.81美元
市场透视 · 2024-12-20
基立福盘中异动 下午盘股价大涨5.05%报7.81美元
基立福盘中异动 股价大跌5.08%
市场透视 · 2024-12-19
基立福盘中异动 股价大跌5.08%
基立福盘中异动 大幅上涨5.18%
市场透视 · 2024-12-18
基立福盘中异动 大幅上涨5.18%
加载更多
公司概况
公司名称:
基立福
所属市场:
NASDAQ
上市日期:
--
主营业务:
GRIFOLS, S.A.由Jose Antonio Grifols i Roig先生于1940年在西班牙巴塞罗那创建成立,公司是全球主要生物制药企业。公司业务涉及血浆系列产品的研发,生产和大范围销售。Grifols股份有限公司的商业活动包括原材料分类、生产各类型血浆提取产品以及将最终产出售并配送给保健品提供商。
发行价格:
--
{"stockData":{"symbol":"GRFS","market":"US","secType":"STK","nameCN":"基立福","latestPrice":8.87,"timestamp":1750190400000,"preClose":9.09,"halted":0,"volume":453116,"hourTrading":{"tag":"盘后","latestPrice":8.87,"preClose":8.87,"latestTime":"16:04 EDT","volume":2002,"amount":17757.739999999998,"timestamp":1750190650113},"delay":0,"floatShares":560961720,"shares":680409104,"eps":0.309265,"marketStatus":"盘后交易","change":-0.22,"latestTime":"06-17 17:06:14 EDT","open":9.07,"high":9.07,"low":8.86,"amount":4058451.26416,"amplitude":0.023102,"askPrice":10.34,"askSize":100,"bidPrice":8.05,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.309265,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1750204800000},"marketStatusCode":4,"adr":1,"adrRate":1,"listingDate":1320120000000,"exchange":"NASDAQ","adjPreClose":9.09,"dividendRate":0.000113,"preHourTrading":{"tag":"盘前","latestPrice":9.08,"preClose":9.09,"latestTime":"09:21 EDT","volume":505,"amount":4580.0401825,"timestamp":1750166515266},"postHourTrading":{"tag":"盘后","latestPrice":8.87,"preClose":8.87,"latestTime":"16:04 EDT","volume":2002,"amount":17757.739999999998,"timestamp":1750190650113},"volumeRatio":0.66259,"impliedVol":0.2177,"impliedVolPercentile":0.184},"requestUrl":"/m/hq/s/GRFS","defaultTab":"news","newsList":[{"id":"2544960195","title":"小摩:维持Grifols(GRFS.US)评级,由中性调整至中性评级, 目标价由7.60美元调整至10.30美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2544960195","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544960195?lang=zh_cn&edition=full","pubTime":"2025-06-17 21:09","pubTimestamp":1750165769,"startTime":"0","endTime":"0","summary":"小摩:维持Grifols(GRFS.US)评级,由中性调整至中性评级, 目标价由7.60美元调整至10.30美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/17210951128613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GRFS"],"gpt_icon":0},{"id":"2539356244","title":"美国法院认定有足够证据推进基立福对卖空机构的诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=2539356244","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539356244?lang=zh_cn&edition=full","pubTime":"2025-05-30 16:47","pubTimestamp":1748594820,"startTime":"0","endTime":"0","summary":"纽约一家法院认定有足够证据,允许西班牙制药公司基立福对卖空机构哥谭市研究公司提起的诽谤诉讼继续进行。 法院认为,有足够证据表明哥谭市研究公司关于基立福未披露向斯克兰顿企业提供 9500 万美元贷款的指控构成诽谤,但驳回了基立福关于不当得利和非法干预的诉求。 哥谭市研究公司未立即回应置评请求。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-05-30/doc-ineyitpa2761816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GRFS","BK4139"],"gpt_icon":0},{"id":"2535871361","title":"基立福盘中异动 下午盘快速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535871361","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535871361?lang=zh_cn&edition=full","pubTime":"2025-05-16 01:32","pubTimestamp":1747330328,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日01时32分,基立福股票出现波动,股价大幅上涨5.15%。截至发稿,该股报7.96美元/股,成交量94.891万股,换手率0.14%,振幅7.77%。基立福股票所在的制药行业中,整体涨幅为1.92%。这些基于蛋白质的疗法延长和改善了患有慢性和急性、通常危及生命的疾病的个体的生活,包括原发性和继发性免疫缺陷、慢性炎症性脱髓鞘性多发性神经病、免疫介导的 ITP。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516013209975ae654&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516013209975ae654&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"gpt_icon":0},{"id":"2535057072","title":"基立福盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535057072","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535057072?lang=zh_cn&edition=full","pubTime":"2025-05-14 23:24","pubTimestamp":1747236260,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日23时24分,基立福股票出现异动,股价大幅下跌5.09%。截至发稿,该股报7.46美元/股,成交量31.1336万股,换手率0.05%,振幅4.26%。基立福股票所在的制药行业中,整体跌幅为2.03%。其相关个股中,Incannex Healthcare Inc.、脑再生科技、Medicus Pharma Ltd.涨幅较大,Incannex Healthcare Inc.、Petros Pharmaceuticals, Inc.、Inmed Pharmaceuticals Inc.较为活跃,换手率分别为3274.23%、1166.22%、156.98%,振幅较大的相关个股有Incannex Healthcare Inc.、Inmed Pharmaceuticals Inc.、Petros Pharmaceuticals, Inc.,振幅分别为607.27%、52.29%、38.33%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514232420aa2c8eba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514232420aa2c8eba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2535707768","title":"基立福盘中异动 大幅上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535707768","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535707768?lang=zh_cn&edition=full","pubTime":"2025-05-13 23:59","pubTimestamp":1747151949,"startTime":"0","endTime":"0","summary":"北京时间2025年05月13日23时59分,基立福股票出现波动,股价快速上涨5.05%。截至发稿,该股报8.12美元/股,成交量44.1375万股,换手率0.06%,振幅5.76%。基立福股票所在的制药行业中,整体跌幅为1.53%。这些基于蛋白质的疗法延长和改善了患有慢性和急性、通常危及生命的疾病的个体的生活,包括原发性和继发性免疫缺陷、慢性炎症性脱髓鞘性多发性神经病、免疫介导的 ITP。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051323590994f5c348&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051323590994f5c348&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"gpt_icon":0},{"id":"2518208390","title":"基立福盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518208390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518208390?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:55","pubTimestamp":1741625733,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时55分,基立福股票出现异动,股价急速跳水5.16%。截至发稿,该股报8.00美元/股,成交量99.304万股,换手率0.15%,振幅2.95%。基立福股票所在的制药行业中,整体跌幅为1.82%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031100553498a2c674&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031100553498a2c674&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"gpt_icon":0},{"id":"2517948832","title":"基立福盘中异动 早盘急速拉升5.02%报8.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517948832?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185081,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分,基立福股票出现异动,股价急速上涨5.02%。截至发稿,该股报8.69美元/股,成交量4.9073万股,换手率0.01%,振幅0.12%。基立福股票所在的制药行业中,整体跌幅为0.20%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223122abe9b081&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223122abe9b081&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2514936389","title":"基立福在西班牙马德里交易所涨幅扩大至12%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514936389","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514936389?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:11","pubTimestamp":1740669067,"startTime":"0","endTime":"0","summary":"基立福在西班牙马德里交易所涨幅扩大至12%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27231148438873.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2514386458","title":"基立福盘中异动 股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514386458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514386458?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:03","pubTimestamp":1740668598,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时03分,基立福股票出现异动,股价大幅拉升5.16%。截至发稿,该股报8.35美元/股,成交量88.3213万股,换手率0.13%,振幅4.91%。基立福股票所在的制药行业中,整体涨幅为0.79%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272303189632b81e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272303189632b81e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"gpt_icon":0},{"id":"2514286863","title":"基立福盘中异动 临近午盘股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514286863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514286863?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:54","pubTimestamp":1740588887,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时54分,基立福股票出现异动,股价大幅上涨5.42%。截至发稿,该股报7.78美元/股,成交量76.5194万股,换手率0.11%,振幅6.91%。基立福股票所在的制药行业中,整体涨幅为0.31%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270054479893c5e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270054479893c5e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"gpt_icon":0},{"id":"2514043656","title":"基立福盘中异动 下午盘股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514043656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514043656?lang=zh_cn&edition=full","pubTime":"2025-02-26 03:23","pubTimestamp":1740511434,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日03时23分,基立福股票出现异动,股价大幅跳水5.11%。截至发稿,该股报7.05美元/股,成交量105.823万股,换手率0.16%,振幅8.34%。基立福股票所在的制药行业中,整体涨幅为1.36%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226032354abdcc195&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226032354abdcc195&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2511863524","title":"基立福盘中异动 早盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511863524","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511863524?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:09","pubTimestamp":1739459395,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时09分,基立福股票出现异动,股价急速上涨5.06%。截至发稿,该股报7.37美元/股,成交量19.5011万股,换手率0.03%,振幅2.50%。基立福股票所在的制药行业中,整体涨幅为0.51%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213230956abcdb976&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213230956abcdb976&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"gpt_icon":0},{"id":"2505112720","title":"基立福盘中异动 早盘大幅下跌5.27%报7.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505112720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505112720?lang=zh_cn&edition=full","pubTime":"2025-01-23 22:31","pubTimestamp":1737642696,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日22时31分,基立福股票出现异动,股价大幅下跌5.27%。截至发稿,该股报7.01美元/股,成交量8.968万股,换手率0.01%,振幅0.27%。基立福股票所在的制药行业中,整体跌幅为0.27%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223136a22d0952&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223136a22d0952&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"gpt_icon":0},{"id":"2505725593","title":"上海莱士预计2025年度与基立福下属公司的交易额为5.2亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505725593","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505725593?lang=zh_cn&edition=full","pubTime":"2025-01-22 19:53","pubTimestamp":1737546826,"startTime":"0","endTime":"0","summary":"与2024年度的实际发生情况相比,基立福全球的交易实际发生金额为4.87亿美元,较预计金额的5.62亿美元有65.73%的差异,主要因市场变化和供货商的实际放行情况影响了采购量。GDS的交易实际发生金额为0.13亿美元,低于预计的0.2亿美元,差异为1.72%。对于海尔生物的交易,2024年实际发生金额为1612万元人民币,远低于预计的金额。文章来源:财中社上海莱士预计2025年度与基立福下属公司的交易额为5.2亿美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122220550a22bab64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122220550a22bab64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2503622235","title":"基立福盘中异动 大幅上涨5.10%报7.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503622235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503622235?lang=zh_cn&edition=full","pubTime":"2025-01-16 01:06","pubTimestamp":1736960792,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日01时06分,基立福股票出现异动,股价快速拉升5.10%。截至发稿,该股报7.42美元/股,成交量52.3064万股,换手率0.08%,振幅3.40%。基立福股票所在的制药行业中,整体涨幅为0.57%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011601063298675f9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011601063298675f9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"gpt_icon":0},{"id":"2502860408","title":"基立福盘中异动 股价大跌5.00%报7.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502860408","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502860408?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:08","pubTimestamp":1736521709,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时08分,基立福股票出现异动,股价快速跳水5.00%。截至发稿,该股报7.22美元/股,成交量14.6785万股,换手率0.02%,振幅1.58%。基立福股票所在的制药行业中,整体涨幅为0.24%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110230829a21d1735&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110230829a21d1735&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"gpt_icon":0},{"id":"2494839382","title":"基立福盘中异动 早盘股价大跌5.10%报7.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494839382","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494839382?lang=zh_cn&edition=full","pubTime":"2024-12-27 23:22","pubTimestamp":1735312922,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日23时22分,基立福股票出现波动,股价快速跳水5.10%。截至发稿,该股报7.45美元/股,成交量25.493万股,换手率0.04%,振幅2.17%。基立福股票所在的制药行业中,整体跌幅为0.38%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202412272322039851df63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202412272322039851df63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2492110089","title":"基立福盘中异动 下午盘股价大涨5.05%报7.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492110089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492110089?lang=zh_cn&edition=full","pubTime":"2024-12-20 02:38","pubTimestamp":1734633494,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日02时38分,基立福股票出现异动,股价快速拉升5.05%。截至发稿,该股报7.81美元/股,成交量54.4987万股,换手率0.08%,振幅4.84%。基立福股票所在的制药行业中,整体跌幅为0.76%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220023814a1fbb85a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220023814a1fbb85a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2492515320","title":"基立福盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492515320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492515320?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:32","pubTimestamp":1734550326,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时32分,基立福股票出现异动,股价急速跳水5.08%。截至发稿,该股报7.64美元/股,成交量46.8777万股,换手率0.07%,振幅4.22%。基立福股票所在的制药行业中,整体跌幅为0.79%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219033207a1f93ea8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219033207a1f93ea8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2492051993","title":"基立福盘中异动 大幅上涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492051993","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492051993?lang=zh_cn&edition=full","pubTime":"2024-12-18 01:19","pubTimestamp":1734455970,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日01时19分,基立福股票出现异动,股价大幅上涨5.18%。截至发稿,该股报8.02美元/股,成交量49.4408万股,换手率0.07%,振幅4.59%。基立福股票所在的制药行业中,整体涨幅为0.73%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121801193095ea34da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121801193095ea34da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.grifols.com","stockEarnings":[{"period":"1week","weight":0.0294},{"period":"1month","weight":0.1714},{"period":"3month","weight":0.1222},{"period":"6month","weight":0.2234},{"period":"1year","weight":0.2986},{"period":"ytd","weight":0.2218}],"compareEarnings":[{"period":"1week","weight":0.005},{"period":"1month","weight":0.0143},{"period":"3month","weight":0.0743},{"period":"6month","weight":0.028},{"period":"1year","weight":0.1104},{"period":"ytd","weight":0.0283}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"GRIFOLS, S.A.由Jose Antonio Grifols i Roig先生于1940年在西班牙巴塞罗那创建成立,公司是全球主要生物制药企业。公司业务涉及血浆系列产品的研发,生产和大范围销售。Grifols股份有限公司的商业活动包括原材料分类、生产各类型血浆提取产品以及将最终产出售并配送给保健品提供商。","yearOnYearQuotes":[{"month":1,"riseRate":0.642857,"avgChangeRate":0.000926},{"month":2,"riseRate":0.571429,"avgChangeRate":0.01741},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.02113},{"month":4,"riseRate":0.5,"avgChangeRate":0.017078},{"month":5,"riseRate":0.5,"avgChangeRate":0.02543},{"month":6,"riseRate":0.5,"avgChangeRate":0.025041},{"month":7,"riseRate":0.642857,"avgChangeRate":0.021434},{"month":8,"riseRate":0.214286,"avgChangeRate":-0.037926},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.021077},{"month":10,"riseRate":0.5,"avgChangeRate":0.002945},{"month":11,"riseRate":0.5,"avgChangeRate":0.020752},{"month":12,"riseRate":0.714286,"avgChangeRate":0.031417}],"exchange":"NASDAQ","name":"基立福","nameEN":"Grifols SA"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.0","shortVersion":"4.34.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"基立福(GRFS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供基立福(GRFS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"基立福,GRFS,基立福股票,基立福股票老虎,基立福股票老虎国际,基立福行情,基立福股票行情,基立福股价,基立福股市,基立福股票价格,基立福股票交易,基立福股票购买,基立福股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"基立福(GRFS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供基立福(GRFS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}